Neurodegenerative Diseases Research Unit, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Department of Pathology (Neuropathology), Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Neurobiol Aging. 2019 Apr;76:214.e1-214.e9. doi: 10.1016/j.neurobiolaging.2018.11.007. Epub 2018 Nov 17.
Molecular genetic research provides unprecedented opportunities to examine genotype-phenotype correlations underlying complex syndromes. To investigate pathogenic mutations and genotype-phenotype relationships in diverse neurodegenerative conditions, we performed a rare variant analysis of damaging mutations in autopsy-confirmed neurodegenerative cases from the Johns Hopkins Brain Resource Center (n = 1243 patients). We used NeuroChip genotyping and C9orf72 hexanucleotide repeat analysis to rapidly screen our cohort for disease-causing mutations. In total, we identified 42 individuals who carried a pathogenic mutation in LRRK2, GBA, APP, PSEN1, MAPT, GRN, C9orf72, SETX, SPAST, or CSF1R, and we provide a comprehensive description of the diverse clinicopathological features of these well-characterized cases. Our study highlights the utility of high-throughput genetic screening arrays to establish a molecular diagnosis in individuals with complex neurodegenerative syndromes, to broaden disease phenotypes and to provide insights into unexpected disease associations.
分子遗传学研究为研究复杂综合征的基因型-表型相关性提供了前所未有的机会。为了研究不同神经退行性疾病中的致病突变和基因型-表型关系,我们对约翰霍普金斯脑资源中心(Johns Hopkins Brain Resource Center)经过尸检证实的神经退行性病例(n=1243 例)中的破坏性突变进行了罕见变异分析。我们使用 NeuroChip 基因分型和 C9orf72 六核苷酸重复分析快速筛查我们的队列中是否存在致病突变。总共,我们确定了 42 名个体携带 LRRK2、GBA、APP、PSEN1、MAPT、GRN、C9orf72、SETX、SPAST 或 CSF1R 的致病性突变,我们提供了这些特征明确病例的广泛临床病理特征的全面描述。我们的研究强调了高通量遗传筛选阵列在具有复杂神经退行性综合征的个体中建立分子诊断的效用,以拓宽疾病表型并深入了解意外的疾病关联。